Digestion, absorption and tissue distribution of ovalbumin and palmitoyl-ovalbumin: Impact on immune responses triggered by orally administered antigens

Scandinavian Journal of Immunology

Volumn 65, Issue 2, 2007, Pages 139-147

  Oliveira, F M ^a   Dos Santos, E M ^a   Alves, A C ^a   Campana Pereira, M A ^a   Ramaldes, G A ^a   Cardoso, V N ^a   Ruiz De Souza, V ^a   Gontijo, C M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; ANTIGEN; OVALBUMIN; PALMITOYL OVALBUMIN; PROTEINASE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LIVER; LYMPH NODE; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN TRANSPORT; SPLEEN; SPLENECTOMY; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; DIGESTION; FEMALE; GASTROINTESTINAL TRACT; MALE; MICE; MICE, INBRED STRAINS; OVALBUMIN; PALMITIC ACIDS; SPLEEN; TISSUE DISTRIBUTION;

EID: 33846612828     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01884.x     Document Type: Article

References (65)

1. Sun ZW, Wang XD, Deng XM et al. The influence of circulatory and gut luminal challenges on bi-directional intestinal barrier permeability in rats. Scand J Gastroenterol 1997;32:995-1004.
2. Lennernãs H. Human intestinal permeability. J Pharm Sci 1998;87:403-10.
3. Boriello P. Bugs and the gut: breaking barriers to understanding gut. Gut 2001;48:503-7.
4. Nagler-Anderson C. Man the barrier! Strategic defences in the intestine mucosa. Nat Rev Immunol 2001;1:59-67.
5. McKenzie BS, Corbett AJ, Johnson S et al. Bypassing luminal barriers, delivery to gut addressin by parenteral targeting elicits local IgA responses. Int Immunol 2004;16:1613-22.
6. Ismail AS, Hooper LV. Epithelial cells and their neighbors. IV Bacterial contributions to intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 2005;289:G779-84.
7. Hu KF, Ekstrom J, Mirza M, Lövgren-Bengtsson K, Morein B. Induction of antibody responses in the common mucosal immune system by respiratory syncytial virus immunostimulating complexes. Med Microbiol Immunol 1999;187:191-8.
8. Hiroi T, Yanagita M, Ohta N, Sakuae G, Kiyono H. IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune-system independent B-1 cells for IgA responses. J Immunol 2000;165:4329-37.
9. Wu HY. Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect Immun 2000;68:5539-45.
10. Cross ML. Immune-signalling by orally delivery probiotic bacteria: effects on common mucosal sites and protection at distal sites. Int J Immunopathol Pharmacol 2004;17:127-34.
11. Boyaka PN, Tafaro A, Fischer R, Fujihashi K, Jirillo E, McGhee JR. Therapeutic manipulation of the immune system: enhancement of innate and adaptative mucosal immunity. Curr Pharm Des 2003;9:1965-72.
12. Elson CO, Ealding W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance induction to an unrelated protein antigen. J Immunol 1984;133:2892-7.
13. Sun JB, Holmgren J, Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A 1994; 91:10795-9.
14. Enomoto A, Konishi M, Hachimura S, Kaminogawa S. Milk whey protein fed as a constituent of the diet induced both oral tolerance and a systemic humoral response, while heat-denatured whey protein induced only oral tolerance. Clin Immunol Immunopathol 1993;66:136-42.
15. Husby SJ, Mestecky Z, Moldoveanu Z, Holland S, Elson CO. oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 1994;152:4663-70.
16. Miller SD, Hanson DG. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J Immunol 1979;123:2344-50.
17. Kay RA, Ferguson A. The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology 1989;66:416-21.
18. Song F, Whitacre CC. The role of the gut lymphoid tissue in induction of oral tolerance. Curr Opin Invest Drugs 2001;2:1382-6.
19. Tlaskalová-Hogenová H, Tucková L, Lodinová-Zádniková R et al. Mucosal immunity: its role in defense and allergy. Int Arch Allergy Immunol 2002;128:77-89.
20. Dubois B, Goubier A, Joubert G, Kaiserlian P. Oral tolerance and regulation of mucosal immunity. Cell Mol Life Sci 2005;62:1322-32.
21. Zho F, Neutra MR. Antigen delivery to mucosa associated lymphoid tissues using liposomes as carrier. Biosci Rep 2002;22:355-69.
22. Gupta RK, Chang AC, Siber GR. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Dev Biol Stand 1998;92:63-78.
23. Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Biodegradable poly (lactic-co-glycolic-acid) microparticles for injectable delivery of vaccines antigens. Adv Drug Deliv Rev 2005;57:391-410.
24. Barrr IG, Mitchell GF. ISCOMs (immunostimulating complexes): the first decade. Immunol Cell Biol 1996;74:8-25.
25. + T cell responses by oral or parenteral immunization with ISCOMS. Eur J Immunol 1995;25:2835-41.
26. Ascón MA, Hone DM, Walters N, Pascual DW. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect Immun 1998;66:5470-6.
27. Mestecky J, Michalek SM, Moldoveanu Z, Russell MW. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Behring Inst Mitt 1997;98:33-43.
28. + T cell response induced by particulate antigen targeted to phagocytic cells. Int Immunol 1997;9:91-103.
29. Gamvrellis A, Leong D, Mottram P, Plebanski M. Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 2004;82:506-16.
30. BenMohamed L, Wechsler SW, Nesburn AB. Lipopetide vaccines - yesterday, today, and tomorrow. LANCET Infect Dis 2002;2:425-31.
31. Bessler WG, Heinevetter L, Wiesmüller KH et al. Bacterial cell wall components as immunomodulators. I. Lipopeptides as adjuvants for parenteral and oral immunization. Int J Immunopharmacol 1997;19:547-50.
32. Michael JG. The role of digestive enzymes in orally induced immune tolerance. Immunol Invest 1989;18:1049-54.
33. Hanson DG, Roy MJ, Green GM, Miller SD. Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg Immunol 1993;5:76-84.
34. Bruce MG, Ferguson A. Oral tolerance to ovalbumin in mice: studies of chemically modified and "biologically filtered" antigen. Immunology 1986;57:627-30.
35. Peng HJ, Turner MW, Strobel S. The generation of a "tolerogen" after ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol 1990;81:510-5.
36. Oliveira FM, Silva-Neto AF, Silva CA, Gontijo CM. Coupling of palmitate to ovalbumin inhibits the induction of oral tolerance. Braz J Med Biol Res 1998;31:1421-4.
37. Oliveira FM, Santos EM, Mota-Santos TA, Ruiz-de-Souza V, Gontijo CM. Covalent coupling of palmitate to ovalbumin inhibits and blocks the induction of oral tolerance. Scand J Immunol 2002;55:570-6.
38. 99mTc-ovalbumin encapsulated in liposomes. Braz Arch Biol Technol 2005;48:235-41.
39. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005;206:235-59.
40. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331-41.
41. Domen PL, Muckerheide A, Michael JG. Cationization of protein antigens. III. Abrogation of oral tolerance. J Immunol 1982;128:1992-8.
42. Peng HJ, Chang ZN, Han SH, Won MH, Huang BT. Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH responses in mice. Scand J Immunol 1995;42:297-304.
43. Streicher HZ, Berkower IJ, Busch M. Antigen conformation determines processing requirements for T-cell activation. Proc Natl Acad Sci U S A 1984;81:6831-5.
44. Collins DS, Unanue ER, Harding CV. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol 1991;147:4054-9.
45. Vidard L, Rock KL, Benacerraf B. Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases. J Immunol 1992;149:498-504.
46. Karlsson M, Lundin S, Dahlgren U, Kahu H, Petterson I, Telemo E. "Tolerosomes" are produced by intestinal epithelial cells. Eur J Immunol 2001;31:2892-900.
47. Jamar F, Houssiau FA, Devogelaer JP et al. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology 2002;41:53-61.
48. Argonne National Laboratory. Human Health Fact Sheet; 2005, 2 pp.
49. Wong A, Toth I. Lipid, sugar and liposaccharide based delivery systems. Curr Med Chem 2001;8:1123-36.
50. Lefèvre ME, Olivo R, Vanderhoff JW, Joel DD. Accumulation of latex particles in Peyer's patches and their subsequent appearance in villi and mesenteric lymph nodes. Proc Soc Exp Biol Med 1978;159:298-302.
51. Ramaldes GA, Pereira MA, Castro PT, Vieira LM, Cardoso VN. Liposomas pelas placas de Peyer de camundongos após administração oral. Braz J Pharm Sci 2002;38:173-82.
52. Rothkotter HJ, Pabst R, Bailey M. Lymphocyte migration in the intestinal mucosa: entry, transit and emigration of lymphoid cells and influence of antigen. Vet Immunol Immunopathol 1999;72:157-65.
53. Gebert A. The role of M cells in the protection of mucosal membranes. Histochem Cell Biol 1997;108:455-70.
54. Song F, Whitacre CC. The role of lymphoid tissue in induction of oral tolerance. Curr Opin Investig Drugs 2001;2:1382-6.
55. Spahn TW, Fontana A, Faria AM et al. Induction of oral tolerance to cellular immune response in the absence of Peyer's patches. Eur J Immunol 2001;31:1278-87.
56. Kunisawa J, Takahashi I, Okudaira A et al. Lack of antigen-specific immune response in anti-IL-7-receptor alpha chain antibody treated Peyer's patch null mice following intestinal immunization with microencapsulated antigen. Eur J Immunol 2002;32:2347-55.
57. Westerberg L, Wallin RP, Greiciu G, Ijuggren HG, Severinson E. Efficient antigen presentation of soluble, but not particulate, antigen in the absence of Wiskott-Aldrich Syndrom protein. Immunology 2003;109:384-91.
58. Kunkel D, Kirchhoff P, Nishikawa S, Radbruch A, Scheffod A. Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches deficient mice. Eur J Immunol 2003;33:1292-301.
59. Fujihashi K, Dohi T, Remset PD et al. Peyer's patches are required for oral tolerance to protein. Proc Natl Acad Sci U S A 2001;98:3310-5.
60. Reddy LH, Murthy RS. Lymphatic transport of orally administered drug. Indian J Exp Biol 2002;40:1097-109.
61. Alpan O, Rudomen G, Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. Immunology 2001;166:4843-52.
62. Barsante MM, Speziali E, Ficker SM, Assis FA, Vaz NM, Faria AMC. Splenectomy does not abrogate oral tolerance induction in mice. Scand J Immunol 2001;54:106-10.
63. Li W, Chou ST, Wang C, Kuhr CS, Perkin JD. Role of the liver in peripheral tolerance induction through oral antigen feeding. Am J Transplant 2004;4:1574-82.
64. Margenthaler JA, Landerosk K, Kataoka M, Flye MW. CD1-dependent natural killer (NK1-1 (+)) T cells are required for oral and portal venous tolerance induction. J Surg Res 2002;104:29-35.
65. Hultkrantz S, Ostman S, Telemo E. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology 2005;116:362-72.